drugset / Trial / NCT04831944
To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of the study is to evaluate the pharmacokinetics and safety of parsaclisib in participants With normal hepatic function and participants with hepatic impairment.
Timeline
- Start
- 2021-03-29
- Primary completion
- 2022-03-10
- Completion
- 2022-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Parsaclisib | Small molecule | — | Oral |